Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can emergency heart data travel safely through the air?

NCT ID NCT05587764

Knowledge-focused Sponsor: Heartstream US LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study looks at whether the Tempus Pro, a portable vital signs monitor used in ambulances, sends accurate ECG (heart) recordings and other vital sign data to doctors via telemedicine. Researchers will compare the transmitted data with the original readings from the device to see if they match. The study involves about 100 patients who were monitored with the device during pre-hospital emergency care. The goal is to confirm the device works reliably for remote monitoring in emergency situations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Tempus Pro multi-parameter vital signs monitoring device
What this could lead to
If the transmitted data matches the original, it could support wider use of telemedicine for remote monitoring in emergencies.
What could go wrong
This is an observational study, so it can't prove the device improves outcomes. Transmission or data quality issues could still occur in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

103 people

The number who actually took part.

Started

Apr 2024

Finished

Aug 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pre- and inter-hospital transfer: emergency patients (adults and pediatrics).

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients monitored by using Tempus Pro during pre-hospital care (ambulance transportation) One or more 12-lead ECG recorded Use of 3 or more of the following sensors to measure vital signs * NIBP (Non-Invasive Blood Pressure) * HR (Heart Rate) * SpO2 (Oxygen Saturation) * PVI (Pleth Variability Index) * SpCO (Carboxyhemoglobin) * SpOC (Oxygen Content) * SpHb (Total Hemoglobin) * SpMet (Methemoglobin Saturation) * EtCO2 (End-tidal Carbon Dioxide) Exclusion Criteria: * None defined

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Emergency care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Death, Sudden, Cardiac sudden cardiac arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Emergency care Sudden cardiac arrest

Contacts and locations

Locations

  • Philips

    Pittsburgh, Pennsylvania, 15206, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.